Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 4 of 4

Full-Text Articles in Medicine and Health Sciences

Incidence Of Anti-Heparin/Platelet Factor 4 Antibodies And Heparin-Induced Thrombocytopenia In Medical Patients [Turkish], M. Demir, E. Tekgündüz, M. Edis, Eyup Duran, T. Kürüm Jun 2013

Incidence Of Anti-Heparin/Platelet Factor 4 Antibodies And Heparin-Induced Thrombocytopenia In Medical Patients [Turkish], M. Demir, E. Tekgündüz, M. Edis, Eyup Duran, T. Kürüm

Eyup Hakan Duran

OBJECTIVE: Heparin-induced thrombocytopenia (HIT) is a life threatening complication of heparin therapy, causing thrombosis. The aim of our study was to find out the frequencies of HIT antibody seroconversion and clinical HIT in Turkish medical patients on different forms of heparins. METHODS: Our study included 61 patients who were on unfractionated heparin (UFH) (n: 37) and low molecular weight heparin (LMWH) (n: 24) therapies. The frequency of HIT antibody formation was determined by means of antigenic (ELISA), and functional assays (serotonin release assay-SRA). RESULTS: The seroconversion rates in UFH and LMWH groups were found to be 18.9% and 4.1% (ELISA), …


Improving Practice Through Research: The Case Of Heparin Vs. Saline For Peripheral Intermittent Infusion Devices, C. Goode, Charmaine Kleiber, M. Titler, S. Small, Barbara Rakel, Victoria Steelman, J. Walker, Kathleen Buckwalter Nov 2011

Improving Practice Through Research: The Case Of Heparin Vs. Saline For Peripheral Intermittent Infusion Devices, C. Goode, Charmaine Kleiber, M. Titler, S. Small, Barbara Rakel, Victoria Steelman, J. Walker, Kathleen Buckwalter

Barbara A. Rakel

Peripheral intermittent infusion devices are commonly used to administer periodic doses of medications to adults and children. Research findings provide a strong base for changing practice to using saline instead of heparin to flush these devices in children over 28 days old and in adults. This research-based change in practice will enhance the quality of care that patients receive and decrease the costs of their care.


Complications In Neonates Associated With Total Daily Heparin Exposure, L. Current, K. Rawlings, Jane Gervasio, M. Mckinney Nov 2009

Complications In Neonates Associated With Total Daily Heparin Exposure, L. Current, K. Rawlings, Jane Gervasio, M. Mckinney

Jane M. Gervasio

Abstract from the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 5-10, 2009.


A Comparison Of The Efficacy Of 0.5 Units/Ml Versus 1 Unit/Ml Of Heparin In Neonatal Parenteral Nutrition, E. Szeszycki, A. Kastner, L. Mobley, Jane Gervasio Jan 2009

A Comparison Of The Efficacy Of 0.5 Units/Ml Versus 1 Unit/Ml Of Heparin In Neonatal Parenteral Nutrition, E. Szeszycki, A. Kastner, L. Mobley, Jane Gervasio

Jane M. Gervasio

Abstract of distinction from ASPEN Nutrition Week, New Orleans, LA, February 1-4, 2009.